COVID-19 and COPD: a narrative review of the basic science and clinical outcomes.
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes.
复制标题
DOI:
10.1183/16000617.0199-2020
复制
发表时间:
2020-12-31
期刊:
影响因子:
--
通讯作者:
Singh D
中科院分区:
文献类型:
--
作者:
Higham A;Mathioudakis A;Vestbo J;Singh D
The 2019 coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Clinical outcomes, including mortality, are worse in males, older individuals and patients with comorbidities. COPD patients are included in shielding strategies due to their susceptibility to virus-induced exacerbations, compromised pulmonary function and high prevalence of associated comorbidities. Using evidence from basic science and cohort studies, this review addresses key questions concerning COVID-19 and COPD. First, are there mechanisms by which COPD patients are more susceptible to SARS-CoV-2 infection? Secondly, do inhaled corticosteroids offer protection against COVID-19? And, thirdly, what is the evidence regarding clinical outcomes from COVID-19 in COPD patients? This up-to-date review tackles some of the key issues which have significant impact on the long-term outlook for COPD patients in the context of COVID-19. This up-to-date review tackles some of the key issues which have significant impact on the long-term outlook for COPD patients in the context of COVID-19 https://bit.ly/36PKzEO
登录
查看更多内容
影响因子:
24.3
作者:
Chalmers, James D.;Laska, Irena F.;Miravitlles, Marc
通讯作者:
Miravitlles, Marc
DOI:
10.1164/rccm.201908-1550oc
发表时间:
2020-05-01
影响因子:
24.7
作者:
Angel Martinez-Garcia, Miguel;Faner, Rosa;Agusti, Alvar
通讯作者:
Agusti, Alvar
影响因子:
24.3
作者:
Cantoli, Marco;Pauletti, Alessia;Papi, Alberto
通讯作者:
Papi, Alberto
影响因子:
5.2
作者:
Benetti, Elisa;Tita, Rossella;Pinto, Anna Maria
通讯作者:
Pinto, Anna Maria
影响因子:
4.8
作者:
Douglas, GC;O'Bryan, MK;Lew, RA
通讯作者:
Lew, RA